Total submissions: 1
            
    | Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment | 
|---|---|---|---|---|---|---|---|---|
| Ambry Genetics | RCV003217732 | SCV003900722 | uncertain significance | Inborn genetic diseases | 2023-02-23 | criteria provided, single submitter | clinical testing | The c.49C>T (p.R17W) alteration is located in exon 2 (coding exon 1) of the SMG9 gene. This alteration results from a C to T substitution at nucleotide position 49, causing the arginine (R) at amino acid position 17 to be replaced by a tryptophan (W). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |